Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 1796 - 1796
Published: Aug. 7, 2024
Bone
tissue
engineering
(BTE)
provides
an
alternative
for
addressing
bone
defects
by
integrating
cells,
a
scaffold,
and
bioactive
growth
factors
to
stimulate
regeneration
repair,
resulting
in
effective
bioengineered
tissue.
This
study
focuses
on
repurposing
chitosan
from
blue
swimming
crab
(
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 3836 - 3836
Published: March 29, 2024
Presently,
millions
worldwide
suffer
from
degenerative
and
inflammatory
bone
joint
issues,
comprising
roughly
half
of
chronic
ailments
in
those
over
50,
leading
to
prolonged
discomfort
physical
limitations.
These
conditions
become
more
prevalent
with
age
lifestyle
factors,
escalating
due
the
growing
elderly
populace.
Addressing
these
challenges
often
entails
surgical
interventions
utilizing
implants
or
grafts,
though
treatments
may
entail
complications
such
as
pain
tissue
death
at
donor
sites
for
along
immune
rejection.
To
surmount
challenges,
engineering
has
emerged
a
promising
avenue
injury
repair
reconstruction.
It
involves
use
different
biomaterials
development
three-dimensional
porous
matrices
scaffolds,
alongside
osteoprogenitor
cells
growth
factors
stimulate
natural
regeneration.
This
review
compiles
methodologies
that
can
be
used
develop
are
important
replacement
Biomaterials
orthopedic
implants,
several
scaffold
types
production
methods,
well
techniques
assess
biomaterials’
suitability
human
use—both
laboratory
settings
within
living
organisms—are
discussed.
Even
researchers
have
had
some
success,
there
is
still
room
improvements
their
processing
techniques,
especially
ones
make
scaffolds
mechanically
stronger
without
weakening
biological
characteristics.
Bone
therefore
area
rise
bone-related
injuries.
Journal of Tissue Engineering,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 1, 2025
Osteonecrosis
of
the
femoral
head
(ONFH)
is
a
prevalent
orthopedic
disorder
characterized
primarily
by
compromised
blood
supply.
This
vascular
deficit
results
in
cell
apoptosis,
trabecular
bone
loss,
and
structural
collapse
at
late
stage,
significantly
impairing
joint
function.
While
MRI
highly
effective
tool
for
diagnosing
ONFH
its
early
stages,
challenges
remain
due
to
limited
availability
high
cost
MRI,
as
well
absence
routine
screening
asymptomatic
patients.
.
In
addition,
current
therapeutic
strategies
predominantly
only
relieve
symptoms
while
disease-modifying
drugs
are
still
under
investigation/development.
Considering
that
supply
plays
key
role
pathology
ONFH,
angiogenic
therapies
have
been
put
forward
promising
treatment
options.
Emerging
bioengineering
interventions
targeting
angiogenesis
hold
potential
treatment.
this
review,
we
introduce
advances
research
into
summarize
novel
angiogenesis.
review
sheds
light
upon
new
directions
future
ONFH.
Stresses,
Journal Year:
2025,
Volume and Issue:
5(1), P. 10 - 10
Published: Jan. 27, 2025
Chitosan
micro-aerogels
(CsM)
are
an
innovative
strategy
for
the
controlled
release
of
healing
and
anti-inflammatory
ingredients.
Although
Bursera
microphylla
has
activity
in
vitro,
its
vivo
effect
is
unknown.
This
study
evaluated
wound-healing
effects
extracts
B.
microphylla.
loaded
with
0.5%
(CsMBT-0.5)
1%
(CsMBT-1)
ethanol
extract
were
characterized
by
SEM,
FTIR,
TGA,
moisture
absorption.
Cytotoxicity
was
assessed
MTT
assay,
vitro
NO
quantification.
Anti-inflammatory
tested
CD1
mice.
The
microparticles
measured
135–180
μm.
FTIR
showed
that
extract’s
compounds
remained
unchanged
during
synthesis.
TGA
indicated
degradation
between
250–350
°C
reduced
absorption
when
extract.
inhibited
36%
at
6.25
μg/mL
CsMBT-1
46%
100
(p
<
0.05).
CsMBT-0.5
mice
ear
swelling
70%
30
mg/mL
0.0001).
wound
size
day
9,
while
accelerated
closure
from
1
0.05),
indicating
chitosan
a
promising
treatment
option.